Market Overview

UPDATE: Stifel Nicolaus Initiates DENTSPLY International at Holdon Generic Implant Risk

Share:
Related XRAY
Daniel Loeb's 7 Largest Stock Purchases In Q4
The 10 Most Expensive Stocks In The S&P 500
By The Numbers: Healthcare Stocks With Big Cash Distributions (Seeking Alpha)

Stifel Nicolaus initiated coverage on DENTSPLY International (NASDAQ: XRAY) with a Hold rating.

Stifel Nicolaus noted, "Diligence points to concerns in the dental implant market, a potential for moderating growth in endodontics, and doctor checks that reveal slightly deteriorating U.S. dental patient volume. Collectively, the implant and endodontic specialty divisions as well as the consumables businesses (preventives and restoratives) account for approximately 70% of DENTSPLY's total revenue (x-precious metals). Despite the stock's current NTM P/E multiple, which reflects a slight discount to its historical average, our work in these various business units keeps us on the sidelines."

DENTSPLY International closed at $39.66 on Wednesday.

Latest Ratings for XRAY

DateFirmActionFromTo
Mar 2018BarclaysInitiates Coverage OnEqual-Weight
Mar 2018JP MorganMaintainsOverweightOverweight
Mar 2018H.C. WainwrightMaintainsNeutralNeutral

View More Analyst Ratings for XRAY
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (XRAY)

View Comments and Join the Discussion!